World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
54
Citations
31804
World Ranking
3601
National Ranking
1559

Overview

Jason Flannick is affiliated with the Broad Institute in the United States. Their research is situated primarily within the fields of Biochemistry, Genetics, and Molecular Biology, with additional work in Medicine. The main subfields of study include Genetics, Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, and Biochemistry.

The researcher's work covers several specific topics, including Genetic Associations and Epidemiology, Bioinformatics and Genomic Networks, Pancreatic function and diabetes, Genomics and Rare Diseases, Diabetes and associated disorders, Biomedical Text Mining and Ontologies, and Epigenetics and DNA Methylation.

Frequent co-authors in their publications include Dongkeun Jang, José C. Florez, Maria C. Costanzo, Noël P. Burtt, and Patrick Smadbeck.

Their research has been published in multiple venues, with the most frequent being bioRxiv (Cold Spring Harbor Laboratory), Diabetes, Nature Genetics, UNC Libraries, and Journal of the Endocrine Society.

Selected recent papers authored or co-authored by Jason Flannick include:

  • Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants, 2022, Nature Genetics
  • The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits, 2023, Cell Metabolism
  • Evaluating human genetic support for hypothesized metabolic disease genes, 2022, Cell Metabolism
  • The Lipid Droplet Knowledge Portal: A resource for systematic analyses of lipid droplet biology, 2022, Developmental Cell
  • The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium, 2021, Diabetes

Best Publications

  • Analysis of protein-coding genetic variation in 60,706 humans

    Monkol Lek;Konrad J. Karczewski;Konrad J. Karczewski;Eric V. Minikel;Eric V. Minikel;Kaitlin E. Samocha

  • Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

    Siddhartha Jaiswal;Pierre Fontanillas;Jason Flannick;Jason Flannick;Alisa Manning

  • Patterns and rates of exonic de novo mutations in autism spectrum disorders

    Benjamin M. Neale;Yan Kou;Li Liu;Avi Ma'Ayan

  • Sequential PAttern mining using a bitmap representation

    Jay Ayres;Jason Flannick;Johannes Gehrke;Tomi Yiu

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Christian Fuchsberger;Jason A. Flannick;Jason A. Flannick;Tanya M. Teslovich;Anubha Mahajan

  • Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

    Jason Flannick;Jason Flannick;Gudmar Thorleifsson;Nicola L. Beer;Nicola L. Beer;Suzanne B R Jacobs

  • Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

    A. L. Williams Amy;A. L. Williams Amy;S. B R Jacobs Suzanne;Hortensia Moreno-Macías;Alicia Huerta-Chagoya

  • Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease

    Angharad M. Roberts;Angharad M. Roberts;James S. Ware;Daniel S. Herman;Daniel S. Herman;Daniel S. Herman;Sebastian Schafer

  • Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population

    Elaine T. Lim;Peter Würtz;Peter Würtz;Peter Würtz;Aki S. Havulinna;Priit Palta;Priit Palta

  • Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.

    Miriam S Udler;Jaegil Kim;Marcin von Grotthuss;Sílvia Bonàs-Guarch

  • Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

    Kyle J Gaulton;Kyle J Gaulton;Teresa Ferreira;Yeji Lee;Anne Raimondo

  • Graemlin: general and robust alignment of multiple large interaction networks.

    Jason Flannick;Antal Novak;Balaji S. Srinivasan;Harley H. McAdams

  • Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

    Anubha Mahajan;Jennifer Wessel;Sara M. Willems;Wei Zhao

  • MAFIA: a maximal frequent itemset algorithm

    D. Burdick;M. Calimlim;J. Flannick;J. Gehrke

  • Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders

    Elaine T. Lim;Elaine T. Lim;Soumya Raychaudhuri;Soumya Raychaudhuri;Stephan J. Sanders;Christine Stevens

  • Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

    Karol Estrada;Karol Estrada;Ingvild Aukrust;Ingvild Aukrust;Lise Bjørkhaug;Noël P. Burtt

  • Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol

    Leslie A Lange;Youna Hu;He Zhang;Chenyi Xue

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Jason Flannick;Tanya M. Teslovich;Anubha Mahajan

  • Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

    Jason Flannick;Gudmar Thorleifsson;Nicola L. Beer;Suzanne B. R. Jacobs

  • Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population

    Elaine T. Lim;Peter Wuertz;Aki S. Havulinna;Priit Palta

Frequent Co-Authors

David Altshuler
David Altshuler Harvard University
Jose C. Florez
Jose C. Florez Harvard University
Leif Groop
Leif Groop Lund University
Michael Boehnke
Michael Boehnke University of Michigan–Ann Arbor
Andrew P. Morris
Andrew P. Morris University of Liverpool
Cecilia M. Lindgren
Cecilia M. Lindgren University of Oxford
Torben Hansen
Torben Hansen University of Copenhagen
Torben Jørgensen
Torben Jørgensen University of Copenhagen
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics can open the door to a diverse range of online degrees and accelerated medical career pathways. Many students interested in genetics also consider related healthcare fields, some of which offer flexible online options and streamlined programs. For instance, if you’re a registered nurse aiming to advance your education, there are rn to bsn no clinical hours options, which allow you to earn your degree without traditional in-person clinical requirements.

Those eager to reach the highest levels of nursing can choose the shortest msn to dnp program, reducing time to a doctorate. Fast-paced learners might consider fast track medical assistant programs, which could lead to a new career in as little as six weeks.

If your focus is on advanced practice, there are convenient, fully dnp online degrees. Each pathway has unique entry requirements and timeframes, helping you tailor your journey based on your background and goals. Online degrees continue to expand, making it easier to balance genetics studies with other healthcare disciplines.

Best Scientists Citing Jason Flannick

Trending Scientists

Recently Published Articles